Research

Vanderbilt biologist Nicole Creanza is the guest editor of a new themed issue of "Philosophical Transactions of the Royal Society B" highlighting interdisciplinary approaches to understanding human evolution. Read More

Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don’t use opioids. Read More

Falling is no joke when you're a senior citizen or have other balance issues. Vanderbilt engineers are working on a 'smart cane' that could help physical therapists spot and treat problems sooner. Read More

Acetaminophen may offer a simple treatment to prevent tissue injury following lung transplant, Vanderbilt researchers have discovered. Read More

Vanderbilt investigators have discovered a role for immune system T cells in slowing the decline in skeletal muscle function in patients with Duchenne muscular dystrophy. Read More

Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer. Read More

Researchers at Vanderbilt University have worked out part of the “wiring diagram” of a signaling system in the brain that has been linked to autism spectrum disorder (ASD). Read More

When they occur among people living with HIV, certain cancers and opportunistic infections are considered by health authorities as AIDS-defining events, or ADEs. Read More

Vanderbilt researchers are comparing two types of weight-loss options to determine which is the most effective in helping obese patients reach a more ideal weight before undergoing kidney transplant surgery. Read More

From Vanderbilt Magazine: James Crowe, director of the Vanderbilt Vaccine Center, hopes to create a universal flu vaccine--permanently eliminating the problem of ineffective or under-effective annual flu shots. Read More

A new study from researchers at Vanderbilt and Harvard universities, published this week in the journal Health Affairs, uses federal health survey data to evaluate community-based efforts to address smoking, obesity and other health conditions such as type 2 diabetes and hypertension. Read More

Craig Lindsley, PhD, co-director of the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD), has been named a fellow of the Royal Society of Chemistry and elected chair-elect of the Section of Pharmaceutical Sciences of the American Association for the Advancement of Science (AAAS). Read More

Investigators in the Division of Allergy, Pulmonary and Critical Care have launched a pilot study to see if patients with idiopathic pulmonary fibrosis (IPF) can tolerate the addition of a commonly used antiviral drug to standard IPF treatments. The research team believes the drug may ultimately help slow progression of the chronic and progressive disease or reverse its course. Read More

Vanderbilt researchers have discovered a role for microtubules — part of the cellular “skeleton” — in organizing the unique sidedness of the epithelial cells that line organs like the intestines. Read More

The DARPA challenge seeks to uncover efficient solutions to our increasingly connected world's equally growing appetite for bandwidth. Read More

A digital hub to be housed at Michigan State University will link Vanderbilt's Slave Societies Digital Archive to eight other digital collections of slave records around the country. Read More

Assistant Professor of Chemistry Steven Townsend explores the role that human breast milk can play as a source of narrow spectrum antimicrobial agents in this VU BreakThru blog. Townsend brought together members of the Vanderbilt Pre-3 Initiative, a 2015 Trans-Institutional Program, to assist with his research. Read More

Vanderbilt researchers have discovered imaging features associated with increased risk for aggressive meningiomas (tumors of the brain membranes) that could help guide surgical planning and patient counseling. Read More

Vanderbilt's efforts to strengthen humanities education through a partnership with three schools expands to Fisk University, thanks to a $1.93 million grant from the Andrew W. Mellon Foundation. Read More

New research reveals a unique mechanism of C. difficile toxin neutralization by a monoclonal antibody, suggesting new therapeutic approaches. Read More